Free Trial

Elevai Labs Q2 2024 Earnings Report

Elevai Labs logo
$1.19 -0.02 (-1.74%)
As of 02:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Elevai Labs EPS Results

Actual EPS
-$16.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Elevai Labs Revenue Results

Actual Revenue
$0.61 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Elevai Labs Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Elevai Labs Earnings Headlines

Elevai Labs, Inc. (NASDAQ:ELAB) Short Interest Down 44.6% in February
Three new patents reveal Elon and Trump’s secret “Project America”
Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR! He says these 5 stocks are trading for less than $2 right now… But they could soon SOAR in Trump’s first 100 days.
Analyzing Elevai Labs (NASDAQ:ELAB) and Inventiva (NASDAQ:IVA)
PMGC files to sell 969,386 shares of common stock for holders
See More Elevai Labs Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elevai Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevai Labs and other key companies, straight to your email.

About Elevai Labs

Elevai Labs (NASDAQ:ELAB), a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

View Elevai Labs Profile

More Earnings Resources from MarketBeat